The Efficacy of Fesoterodine Switched from Solifenacin for Overactive Bladder Patients

DOI IR (HANDLE) Web Site Open Access

Bibliographic Information

Other Title
  • 過活動膀胱患者のソリフェナシンからフェソテロジンへの変更の有用性
  • カカツドウ ボウコウ カンジャ ノ ソリフェナシン カラ フェソテロジン エ ノ ヘンコウ ノ ユウヨウセイ

Search this article

Description

We investigated the efficacy of Fesoterodine, in 51 patients who did not respond to treatment with Solifenacin from January 2017 to December 2018. We assessed the overactive bladder symptom score (OABSS), thirst, constipation, and residual urine at baseline, as well as at 3 and 6 months from the start of drug administration. The mean age of the patients was 83. 0±6. 55 years. The OABSS indicated significant improvement in urge urinary incontinence and residual urine at 6 months, and significant aggravation in urgency at 3 months. Thus, Fesoterodine is considered useful for patients who did not respond to treatment with Solifenacin.

Journal

  • 泌尿器科紀要

    泌尿器科紀要 66 (6), 165-170, 2020-06-30

    泌尿器科紀要刊行会

Keywords

Details 詳細情報について

Report a problem

Back to top